War in Gaza

Brendan O'Hara Excerpts

Tuesday 7th May 2024 Commons Chamber

[Mr Speaker]

I call the SNP spokesperson.

[Brendan O’Hara (Argyll and Bute) (SNP)]

A week ago from that Dispatch Box, the Minister said:

“Given the number of civilians sheltering in Rafah, it is not easy to see how such an offensive could be compliant with international humanitarian law”.—[Official Report, 30 April 2024; Vol. 749, c. 141.]

Despite repeated appeals for Israel not to attack Rafah, just hours after the dashed hopes of a ceasefire, that offensive is happening. Is this the breach of international humanitarian law you referred to last week, and will that breach immediately end UK sales of arms to Israel? Or is this yet another example of the UK declaring a red line only for Israel to completely ignore it without condemnation or consequence? We know how this plays out, Minister. You plead with them, they ignore you, they do what they want and you find excuses for them. A blind eye will be turned to the slaughter of tens of thousands of innocent civilians, and while the UK Government call for more aid to the survivors, they will continue to issue arms export licences. That has been the pattern of behaviour for seven months. Can we expect anything different now?

[Mr Mitchell]

On the hon. Gentleman’s final point, he will know that we are working flat out in these very difficult circumstances to achieve something different, and we will continue to do so. He quoted what I said the last time I was at the Dispatch Box, and I would point out that the words I have used today, in answering the same question, are virtually exactly the same. I have made it clear that there would have to be a plan that respected international humanitarian law, and we have not yet seen such a plan. That is entirely consistent with what I said before.

The hon. Gentleman asked about the sale of arms. The Foreign Secretary announced on 9 April that the British position with regard to export licences is unchanged. We do not publish the Government’s legal advice, but we always act in accordance with it. I would point out that we publish data on export licensing decisions transparently and on a quarterly basis.